Home Blog Page 3

Metro Inc. AGM 2026: Shareholders Re-elect 11 Directors With Strong Support

0

Metro Inc. has released the voting results from its Annual General Meeting (AGM) held on January 27, 2026, confirming that shareholders re-elected the full slate of management’s director nominees. The company reported that all 11 proposed candidates were elected to serve until the next AGM (or until successors are appointed or elected).

Metro describes itself as a food and pharmacy leader in Québec and Ontario, with annual sales of more than $22 billion.

Where and when the AGM took place

The AGM was held Tuesday, January 27, 2026 at Lumi Experience in Montréal and was also available by live webcast, according to the company’s investor relations posting.

Who was elected (and what the vote tells us)

Metro reported strong support across the slate, with “votes for” ranging from 94.33% to 99.96%. The highest withheld percentage among the nominees was 5.67%, with the remainder of the slate receiving withheld levels at or below 2.67%.

The elected directors were:

  • Lori-Ann Beausoleil
  • Maryse Bertrand
  • Pierre Boivin
  • Geneviève Brouillette
  • Stephanie Coyles
  • Geneviève Fortier
  • Marc Guay
  • Eric R. La Flèche
  • Brian McManus
  • Michael Motz
  • Pietro Satriano

Metro’s governance page also identifies Pierre Boivin as Chair of the Board and Eric La Flèche as President and Chief Executive Officer (and a director).

Full voting results (as reported)

Nominee Votes For For (%) Votes Withheld Withheld (%)
Lori-Ann Beausoleil 165,449,083 97.99% 3,389,354 2.01%
Maryse Bertrand 159,262,833 94.33% 9,575,604 5.67%
Pierre Boivin 167,304,931 99.09% 1,533,506 0.91%
Geneviève Brouillette 168,767,827 99.96% 70,610 0.04%
Stephanie Coyles 164,328,298 97.33% 4,510,139 2.67%
Geneviève Fortier 165,448,280 97.99% 3,390,157 2.01%
Marc Guay 167,678,039 99.31% 1,160,398 0.69%
Eric R. La Flèche 167,959,892 99.48% 878,545 0.52%
Brian McManus 166,060,644 98.35% 2,777,793 1.65%
Michael Motz 168,595,441 99.86% 242,996 0.14%
Pietro Satriano 168,538,193 99.82% 300,244 0.18%

Metro added that it “congratulates the directors for their election.”

Why board continuity matters

Continuity at the board level can point to stability in leadership oversight and fewer abrupt governance pivots, especially in large, multi-banner operators. Metro says it operates or services a network of about 1,007 food stores and 637 drugstores, spanning banners that include Jean Coutu and Brunet, and employs more than 97,000 people.

Metro’s investor relations page lists the next AGM date as Tuesday, January 26, 2027.

Skin Meets Gut: The New Sales Playbook Behind Holistic Aesthetic Care

0

The skin–gut connection has become a buying trigger, not just a wellness idea

The skin–gut conversation used to live in niche corners of functional nutrition and integrative skincare. Now it shows up where retail decisions actually happen: at the shelf, in the treatment room, on TikTok search, and inside the customer’s own pattern recognition. Shoppers are increasingly convinced their skin is not a standalone surface problem. They see it as a dashboard that reacts to what they eat, how they sleep, how stressed they are, and whether their digestion feels “off.”

That shift is quietly changing the way people shop. Instead of hunting for a single “miracle” product, they are building a personal system. They want fewer steps, clearer roles, and outcomes that feel predictable. They also want the story to make sense. When a customer believes their breakouts are linked to gut upset, or that dryness worsens when digestion is sluggish, they become far more open to a routine that includes ingestibles and habits alongside topical care.

For marketers, this is the moment to stop treating beauty-from-within as a side category. It is becoming a conversion language that lifts multiple aisles at once, especially where natural health meets skincare. For retailers, it is a rare opportunity to increase average order value without relying on discounting, because the purchase logic is additive: the routine only feels complete when it includes more than one element.

Routine architecture is the merchandising move that turns interest into higher baskets

If you merchandise the skin–gut connection like a single SKU story, you will get curiosity and low conversion. If you merchandise it like a routine, you will get commitment. The winning retail layout is not “a collagen shelf” or “a probiotics shelf.” It is a small destination that visually communicates a three-part system: a topical foundation, an ingestible support, and one simple habit that makes the customer feel in control.

This approach works because it mirrors how shoppers think in 2026. They want a plan they can follow, not a product they have to “figure out.” The best retailers are building micro-collections that feel prescriptive without sounding clinical. The language is consumer-friendly but intelligent: “barrier support,” “calm and balance,” “microbiome-aware,” “texture and glow,” “sensitive and stressed.” It feels like modern wellness, not old-school supplement talk.

Place matters. In natural health, digestive support is already a high-frequency aisle with strong repurchase behaviour. That makes it the best gateway to beauty outcomes. A cross-merchandising bridge between gut and skin creates a natural flow: digestion first, appearance second, with the routine tying them together. If you run e-commerce, the same structure should appear on the page as a “complete routine” module that makes the add-on feel logical rather than salesy.

The most important merchandising detail is expectation-setting. Beauty-from-within products often need weeks of consistency to feel meaningful. When staff and signage clearly communicate a realistic timeline, returns drop, trust rises, and repeat rates improve. In-store, a simple “start here” routine card can do more than a dozen product claims because it gives the shopper a next step that feels doable.

Marketing that converts sounds scientific, stays human, and never overpromises

The skin–gut trend is powerful, but it is also easy to ruin with sloppy claims. Shoppers are more informed than ever, and they punish exaggeration. Your marketing has to thread a needle: credible enough to feel evidence-led, simple enough to be understood in five seconds, and careful enough to stay compliant.

The best-performing message format right now is mechanism-first storytelling, because it lets you sound smart without claiming to treat anything. You are not selling “a cure for acne.” You are selling a routine that supports balance and comfort in a way that many customers associate with clearer-looking skin. That distinction is everything.

To make this work, marketers should build creative around three ideas: “support the barrier,” “support balance,” and “support consistency.” Those ideas can live across packaging, PDPs, shelf talkers, and staff scripts without turning into medical claims. They also scale beautifully into content, because they give you a framework for education without sounding like a lecture.

This is also where AEO matters. People are asking the same questions repeatedly in search and social search, and the brands that answer clearly win attention and trust. You can embed the answers directly in your product pages and landing pages in a natural, magazine-like way. A customer is essentially asking, “Does gut health affect skin?” Your copy should respond like a calm expert: the gut and skin communicate through inflammation and microbiome pathways, and some people notice their skin changes when their digestion, sleep, or stress shifts. Then you pivot to routine: start simple, choose a plan, be consistent, track what changes.

The content strategy that performs best is not flashy ingredient obsession. It is routine-led content that makes the shopper feel guided. Think “the minimalist routine for reactive skin,” “the glow routine for people who hate complicated skincare,” “the travel routine for digestion and breakouts,” “the post-treatment routine for calmer-looking recovery.” These themes sell because they mirror real life.

How to turn the trend into repeat customers, premium positioning, and measurable growth

Holistic aesthetic care is not just a trend; it is a retail model that can improve margins when executed well. The reason is simple: routines drive attachment, and attachment drives repeat. When customers buy a single product, you are competing on price and novelty. When customers buy a routine, you are competing on trust and results they can stick with.

Start by deciding what “good” looks like for your store. If you want this category to be a growth engine, measure routine attachment rate, not just unit sales. Track how often a shopper who buys a beauty-from-within item also buys a topical companion, and how often they repurchase within 30, 60, and 90 days. This category is habit-driven, so retention becomes your scoreboard.

Next, modernise the premium story. The skin–gut narrative naturally supports a higher-value positioning because it frames beauty as whole-person care rather than surface correction. That makes it easier to sell quality, testing, transparency, and regimen simplicity. In other words, you are not asking customers to spend more because the product is “stronger.” You are asking them to spend smarter because the routine is clearer and easier to sustain.

Finally, train your team to sell confidence, not complexity. Most customers do not want ten options. They want one good plan. The role of the associate is to reduce uncertainty: pick the routine that matches the customer’s priority, set expectations, and provide a simple tracking habit. When the shopper feels guided, conversion rises and returns fall, because the purchase feels intentional.

If you want a single sentence that captures the opportunity, it is this: the skin–gut connection is transforming beauty retail from product-selling into routine-building. The retailers who embrace that shift will not only sell more, they will sell better.

Pepzyme AG and the New Collagen Playbook for GLP-1 Nutrition

0

The GLP-1 era is rewriting what “support” means

GLP-1 medications have moved metabolic health into the mainstream, and that shift is now influencing the supplement aisle as much as it’s shaping clinical conversations. As more consumers adopt GLP-1 therapies for weight management, brands are being pushed to think beyond generic “protein” messaging and build solutions that match the real-world needs that show up once appetite changes. Smaller meals, inconsistent protein intake, and digestive discomfort can make it harder for users to hit daily targets, even when motivation is high.

At the same time, the most commercially important insight for brands is this: weight loss is not the only outcome that matters. Many users are actively looking for ways to preserve lean mass and support structural health while they reduce body weight. That creates a clear opening for collagen, but only if collagen can be positioned with a stronger nutritional rationale than beauty alone.

Why collagen needs a smarter digestion story

Collagen has become a staple ingredient because it’s familiar, easy to formulate, and widely associated with hair, skin, nails, joints, and mobility. But in the GLP-1 context, the conversation is evolving. Collagen is being reframed as a protein source that could play a structural role during periods of reduced intake, when muscle and bone support become more top-of-mind.

The challenge is that consumer demand has matured. Today’s metabolic-health shopper wants evidence and mechanism, not a broad promise. That’s where the digestion narrative becomes central: collagen only becomes truly useful when it’s broken down into peptides that the body can absorb and utilize efficiently. If digestion is compromised, or if the protein isn’t being broken down as well as it could be, the value proposition weakens.

Pepzyme AG is being positioned as a direct response to that gap, offering a formulation approach that focuses less on “add more collagen” and more on “help the collagen you already use perform better.”

What Pepzyme AG adds to the formulation conversation

Pepzyme AG is a proteolytic enzyme blend designed to support collagen breakdown during digestion and increase the release of low-molecular-weight peptides. In practical terms, the story is simple: it aims to help collagen turn into smaller, more bioactive fragments that are easier for the body to use.

The ingredient’s key claim is that it enhances collagen digestion under a standardized, widely recognized in vitro digestion model. The relevance for product developers is not academic. Standardized digestion methods have become increasingly important because they allow brands to speak about digestion performance in a way that’s more consistent and comparable than older “in-house” models. For marketing teams, that translates into a clearer scientific backbone for premium positioning.

Beyond improved breakdown, the more commercially distinctive angle is peptide function. Pepzyme AG is associated with increased release of peptides that demonstrate improved DPP-IV inhibitory activity in vitro. That matters because DPP-IV is the enzyme that breaks down endogenous GLP-1 in the body. While in vitro activity is not the same as a clinical outcome, it provides a mechanistic narrative that aligns with the direction of the market: supporting the body’s natural GLP-1 activity and complementing the broader metabolic-health lifestyle consumers are building around therapy.

From “beauty collagen” to “metabolic collagen”

For collagen brands, the strategic opportunity here is positioning. The category has long relied on familiar claims and lifestyle visuals, but GLP-1 is changing buying behaviour. Consumers are scrutinizing labels, looking for functional stacks, and favouring products that feel designed for their new routines. In that context, collagen can shift from a general wellness add-on to a functional ingredient that supports both structural needs and metabolic priorities.

Pepzyme AG is being marketed as the bridge that makes this repositioning easier. Rather than asking brands to abandon collagen’s traditional identity, it allows them to evolve it: collagen becomes less about vague “support” and more about digestive performance, peptide delivery, and formulation credibility. It also gives brands a more defensible answer when consumers ask the most important question in modern nutrition: why this product, and why now?

The biggest takeaway for the functional ingredient community is that GLP-1 users represent more than a fast-growing segment. They represent a new standard for how products must be built and explained. Collagen brands that adapt to this standard with science-led formulation upgrades will be better positioned to stand out in a crowded market where differentiation increasingly depends on mechanism, not marketing.

Buy Canadian 2026: The Value + Proof Marketing Playbook

0

The “Buy Canadian” movement has evolved from boycott energy to value-driven pragmatism. Here’s how health food retailers can convert patriotism into sustainable growth.

The movement didn’t fade. It professionalized.

The “Buy Canadian” surge that dominated conversations in 2025 has entered a new phase. The loudest part of the story has quieted, but the behaviour is still there—now guided by a sharper set of shopper rules: make it easy to find, easy to verify, and easy to afford.

For health food and wellness retailers, this is not a trend to chase. It’s a structural shift you can build into your operating system. Why? Because your customer already shops with a higher bar for truth. Wellness shoppers read labels. They ask questions. They expect receipts—literal and figurative. That means “Canadian-first” can become a durable advantage if you execute it like infrastructure, not a campaign.

The strategic question for 2026 is straightforward: when the next wave of cross-border tension hits the news cycle, will your shelves, website, staff, and pricing be ready to convert Canadian sentiment into repeatable, profitable behaviour?

The behaviour engine: what’s actually driving 2026

Identity plus economics: the dual engine

“Buy Canadian” persists because it runs on two tracks simultaneously. One is identity: shoppers want purchases that reflect who they are and what they stand for. The other is economics: cost-of-living pressure forces trade-offs at checkout.

In 2026, economics is the stricter boss. Shoppers may want to support Canadian brands, but they won’t do it if it feels like a premium tax. This is why the movement’s centre of gravity has shifted from broad boycott talk to practical substitutions in everyday baskets—food, essentials, personal care, and the wellness staples that sit adjacent to grocery.

The trust multiplier effect

Wellness retail benefits from a built-in advantage: your category already operates inside a trust contract. Customers come to you because they want fewer surprises—cleaner ingredients, clearer sourcing, better accountability. That makes “Canadian” an accelerant when it’s presented as a trust signal rather than a patriotic banner.

In other words, your best “Buy Canadian” messaging doesn’t sound like politics. It sounds like quality control.

The affordability ceiling

The most important limiter in 2026 is affordability. Many consumers are trading down, shopping promotions harder, and leaning into value retailers. This changes the marketing job. The goal is no longer to persuade people to care about Canadian products. They already do. The goal is to protect the choice from sticker shock.

The international echo

A final wrinkle: origin scrutiny is spreading. Even when the movement is framed as Canadian, the shopper mindset can extend into broader questions about global supply chains, ownership, and where ingredients originate. This matters in wellness, where formulation and sourcing are often international even when the final product is made locally.

The solution is not to hide complexity. It’s to translate it clearly.

The 2026 playbook: five strategic moves

1) Frictionless discovery: own the scan moment

In 2026, discovery is the battleground. Shoppers want Canadian options, but they won’t work for them. You need to win the “scan moment”—the five seconds in front of shelf or search results where the decision happens.

What to do in the next 90 days

  • Build a Canadian-first navigation layer everywhere: shelf tags, endcaps, aisle blades, e-commerce filters, and a consistent weekly flyer module.
  • Treat “Canadian” like a product attribute, not a campaign: it should be sortable, searchable, and visible at a glance.
  • Train staff to explain your Canadian labels in one sentence, confidently and consistently.

2) Reframe patriotism as wellness trust

The winning story is not flag-waving. It’s accountability. Canadian-first should be framed as closer supply chains, clearer standards, better traceability, and fewer surprises.

What to do in the next 90 days

  • Add proof points to shelf talkers and product pages: where it’s made, what’s sourced where, ownership clarity, and the specific meaning of your Canadian callouts.
  • Launch a “Meet the Maker” series: short, staff-led videos that turn Canadian brands into human stories—facility, sourcing, and why their standards matter.
  • Build a simple “Canadian Proof” template for suppliers to fill out so your claims stay consistent across all channels.

3) Price architecture: protect the movement from sticker shock

If Canadian-first equals “more expensive,” you lose the trade-down shopper—even if they want to support Canada. Your job is to keep trading down inside the Canadian set.

What to do in the next 90 days

  • Create Canadian Value Heroes: 10–20 SKUs per major category with reliable promo cadence and visible placement.
  • Build Good / Better / Best tiers inside Canadian sets so value shoppers can step down without stepping out.
  • Use price-pack strategy: trial sizes, bundles, and subscriptions for Canadian staples.

4) Assortment strategy: treat Canadian substitution as category growth

This is where marketing leaders can unlock real growth. When Canadian substitutes exist, give them the structural advantages imports often enjoy: distribution priority, feature space, education, and repeat promotions.

What to do in the next 90 days

  • Run a Canadian Swap Map across top categories:
    • High substitutability: snacks, pantry staples, tea, many personal-care basics, and selected supplement segments.
    • Low substitutability: specialty actives and certain niche formulations.
  • Where substitutes exist: feature them, bundle them, educate staff on the “why,” and build trial through sampling or “switch and save” mechanics.
  • Where substitutes don’t exist: be transparent and credible. Shoppers can accept complexity; they don’t forgive spin.

5) Communications that land: forward-thinking, not cringe

The movement is strong, but consumers are tired of empty posturing. Your messaging should feel modern, calm, and specific.

Messaging framework for 2026
“Canadian-first when it counts. Transparent always.”

This line works because it respects two truths at once: shoppers care about Canada, and they also care about honesty, affordability, and real-world nuance.

The credibility trap: get your Canadian definitions right

The fastest way to damage trust is a vague or inconsistent origin claim. Build one internal standard, stick to it, and make sure your shelf tags match what your products can substantiate.

Practical rule for marketing teams

  • Avoid “local-ish” language.
  • Use clear categories such as:
    • Made in Canada (with a qualifier if needed)
    • Product of Canada (where applicable)
    • Canadian-owned
    • Made in Canada with imported ingredients
    • Packed in Canada (only if that’s the truth)

Then ensure every claim has a proof file you can produce if challenged.

The VP dashboard: metrics that prove it’s working

If you can’t measure Canadian-first, you can’t scale it. Track these weekly:

  • Canadian SKU penetration: percent of category sales from Canadian-made/Canadian-owned products (based on your internal definitions)
  • Basket mix shift: percent of basket value from Canadian-tagged items
  • Filter adoption: percent of online sessions using Canadian filters or Canadian search terms
  • Promo elasticity: lift on Canadian Value Heroes versus imported comparables
  • Claims compliance rate: percent of Canadian shelf tags and PDP badges backed by supplier proof files
  • Staff confidence score: percent of staff who can explain your Canadian labels accurately and consistently

The strategic outlook: build it now, benefit later

“Buy Canadian” isn’t fading. It’s becoming operational. The winners in 2026 won’t be the retailers with the most patriotic creative. They’ll be the ones who built Canadian-first into the way people shop—through discovery infrastructure, proof-based storytelling, value architecture, and staff confidence.

Do that, and the next wave of trade rhetoric won’t feel like a marketing scramble. It will feel like a tailwind you’re already built to capture.

Zellers’ Zellers 3.0 Comeback Builds Momentum After Edmonton Store Launch, With National Expansion in Sight

0

Zellers is building momentum after opening its first new standalone store at Londonderry Mall in Edmonton last October, positioning the “Zellers 3.0” concept as a modern, value-driven take on the department store experience. The retailer says the launch has delivered strong traffic, enthusiastic customer response, and performance that continues to exceed internal expectations—an early signal that Canadians still want a convenient, affordable, multi-category shopping destination, especially when it is wrapped in a familiar name.

A comeback rooted in nostalgia, built for today’s shopper

From opening day onward, the Edmonton location welcomed waves of customers eager to experience the refreshed Zellers firsthand. The store’s approachable format—designed to feel easy to navigate—helped turn curiosity into immediate engagement. Shoppers responded positively to the blend of accessible pricing, a curated product mix, and brand elements that tap into long-standing emotional connection.

One of the most visible examples was the in-store return of Zeddy, Zellers’ beloved mascot. For families and longtime fans, that moment reinforced the brand’s place in Canadian retail culture and helped translate nostalgia into a shared in-store experience. For Zellers, it also underscored a key advantage: few retail brands have built-in cultural memory powerful enough to bring customers in the door before they have even seen the assortment.

A curated small-format department store model

The Edmonton store introduced a focused assortment across men’s, women’s, kids’ and baby apparel, along with footwear, accessories, home essentials, and seasonal categories. Zellers says shoppers were drawn to a mix of recognizable national and global brands alongside everyday lifestyle staples—an assortment strategy that aims to create “high perceived value” without overwhelming customers.

That product strategy matters because the Zellers 3.0 model is not trying to replicate the sprawling department stores of the past. Instead, it is leaning into a smaller-format approach that prioritizes clarity, discoverability, and repeat-visit convenience. In a market where consumers are often balancing price sensitivity with expectations for quality and choice, an edited department store can feel like a practical middle ground—more variety than a single-category retailer, but more efficient than legacy big-box formats.

Why the momentum matters for the functional food and CPG ecosystem

For consumer packaged goods companies and health-forward lifestyle brands, a potential Zellers expansion creates an important watchpoint. A growing chain of small-format department stores can become a meaningful traffic driver in malls and urban hubs—especially when the retailer is positioned as value-led, family-friendly, and seasonal in its merchandising approach.

While the current assortment mix leans heavily into apparel and home, the retailer’s public focus on evolving categories and adding brands over time suggests that supplier opportunities could widen as the concept matures. Retailers that can generate sustained foot traffic also tend to become stronger promotional partners, offering suppliers new access to family shoppers, impulse purchases, and seasonal bundle behaviour—all of which are relevant to the broader CPG landscape.

Executive commentary: exceeding internal targets

“Launching our first store exceeded our expectations in every way,” said Joey Benitah, Chief Operating Officer of Zellers. He noted that the initial opening-day excitement has continued, with consistent customer traffic, overwhelmingly positive feedback, and sales performance that continues to surpass internal targets. For the company, the sustained response validates both the strength of the Zellers name and the demand for a modern department store experience built around approachable value.

The takeaway is not simply that nostalgia sells. It is that nostalgia can be an efficient customer acquisition lever—if the store experience delivers real utility once shoppers arrive. Zellers is signalling that it believes it has found that balance: familiar brand DNA with a contemporary retail model.

Looking ahead: national expansion strategy

Following the Edmonton debut, Zellers says it is actively pursuing new leasing opportunities across Canada as part of a phased national expansion strategy. The company’s goal is to bring stores back to communities across the country, with an emphasis on securing locations in every major Canadian market. It also says it is keeping flexibility at the centre of its real estate approach to support thoughtful, sustainable growth.

At the same time, the retailer says it is listening closely to customer feedback to guide how it expands the assortment, refines the store experience, and introduces new categories and brands. Additional announcements related to new store locations, expanded assortments, and future phases of the Zellers 3.0 concept are expected in the coming months.


Eshbal Maps a North American Growth Plan for 2026

0

Eshbal Functional Food Inc. (TSXV: ESBL) is moving into 2026 with an expansion strategy designed to translate an established Israeli manufacturing base into a scalable North American platform for gluten-free and “better-for-you” foods. In a year-end message, CEO Tomer Bar Meir positioned 2025 as a pivotal year, marked by the company’s public listing and the operational decisions needed to accelerate growth while improving profitability.

Eshbal describes itself as a food-tech operator with more than 20 years of proprietary process development and a broad product engine, having developed more than 300 SKUs, including more than 80 in “better-for-you” segments. The company operates from a roughly 60,000-square-foot production facility in Israel, with an in-house lab and food engineering support. Management also highlighted continued revenue momentum, reporting 2024 revenue of US$11.4 million and forecasting 2025 revenue of up to US$14 million, with an estimated gross margin of 24 per cent.

A public-market platform built to fund growth

The strategic logic behind the April 2025 TSX Venture Exchange listing, according to management, was straightforward: North America is too large to enter cautiously. Capital, inventory, and commercial execution capacity are required to compete in gluten-free bakery, where consumers demand taste parity and retailers expect strong service levels. Eshbal’s plan leans into that reality by combining platform acquisition, local manufacturing, and multi-channel go-to-market execution.

U.S. distribution via D2BD and a Northeast retail footprint

A key milestone late in 2025 was Eshbal’s 55 per cent purchase of U.S.-based Dare To Be Different Foods (D2BD), which management described as having an established footprint across parts of the Northeast, including Walmart locations in New York State and additional stores across New York, New Jersey, and Connecticut. Eshbal’s intent is to use D2BD as a commercial platform, expanding distribution while introducing Eshbal brands into existing store relationships and improving operational performance through tighter quality, efficiency, and cost controls.

Canadian manufacturing, DTC rollout, and broker-led retail expansion

On the manufacturing side, Eshbal says it has secured an Ontario-based gluten-free production partner in Toronto-based Queen Street Bakery. The agreement is expected to begin with pita bread production, supported by Eshbal’s specialised equipment and technical know-how, with additional products potentially following. Initial production is planned to support online inventory, buyer sampling for retail and foodservice evaluations, and early customer opportunities.

To convert operational progress into demand, Eshbal plans to launch a Shopify-based online platform in the first quarter of 2026, pairing brand communication with e-commerce and marketplace integration. Wholesale expansion is expected to be broker-led in the U.S. via Active Marketing Group, initially representing Eshbal’s Barili products alongside select D2BD items, while the company explores Canadian broker representation and pursues foodservice relationships.

Looking ahead, Eshbal says its M&A strategy targets at least one accretive acquisition annually, with the possibility of another U.S.-based acquisition in the first half of 2026. The company’s near-term success will hinge on execution: consistent Canadian production, seamless fulfilment, disciplined integration of D2BD, and retail and foodservice wins that build repeat purchase velocity without eroding margins.

TRUBAR’s Going-Private Deal Clears Final Court Approval

0

TRUBAR Inc. (TSXV: TRBR; OTCQX: TRBRF) has reached a major milestone in its proposed acquisition after the Supreme Court of British Columbia issued a final order approving the company’s plan of arrangement. The transaction involves 1564128 B.C. Unlimited Liability Company (the Purchaser), an affiliate of ETİ Gıda Sanayi ve Ticaret A.Ş. (ETİ Gıda), a leading privately held consumer packaged goods (CPG) company based in Turkey.

With the final order in place, TRUBAR is now positioned to complete the arrangement once customary closing procedures are finalized. The company has indicated closing is expected in the coming weeks, subject to the remaining closing steps.

What the final court order signals

In Canadian M&A, a plan of arrangement typically requires multiple checkpoints: a structured approval process, securityholder support, and court oversight. A final court order is a key green light that confirms the transaction process meets the legal requirements under the arrangement framework. For investors and industry watchers, it is often the clearest indicator that the deal is moving from “announced” to “closing track.”

Why this acquisition matters for better-for-you and natural health

TRUBAR has built its brand in the “better-for-you” snack space with plant-based protein products positioned around taste, quality, and clean, recognizable ingredients. For the natural health channel and functional food ecosystem, this deal is another sign that strategic CPG buyers continue to place value on brands that combine:

  • Clear positioning (plant-based protein and modern ingredient expectations)
  • Strong retail viability (repeat purchase potential and high-velocity shelf performance)
  • Scalable brand architecture (product line extensions and geographic expansion potential)

For ETİ Gıda, the acquisition represents a direct path into the North American better-for-you snacking segment through a brand that has already done the work of building awareness, retail relationships, and consumer trust.

What to watch next

If the arrangement closes as anticipated, TRUBAR is expected to transition out of public markets, with delisting and related reporting changes typically following completion. Next signals will include the closing news release, timing updates, and any early commentary on growth priorities under the new ownership structure.

Organic NatureKnit Outperforms Purified Fibres in Gut Simulation

0

Research highlights gentle fermentation, broader microbiome modulation, and higher SCFAs versus purified organic fibres at 48 hours.

A newly published study in Frontiers in Nutrition is shining a spotlight on Organic NatureKnit®—an all-natural, organic, and patent-pending gut-health innovation from FutureCeuticals—after researchers observed meaningful prebiotic activity and broad microbiome modulation in a validated, lab-based human gut simulation.

Conducted in partnership with ProDigest, a microbiome research organization based in Ghent, Belgium, the work evaluated Organic NatureKnit using ProDigest’s widely recognized M-SHIME® platform. The model is designed to simulate key aspects of the human gastrointestinal tract and the microbial ecosystem, enabling researchers to observe how ingredients influence microbial activity over time under controlled conditions.

Why this study is drawing industry attention

Prebiotics remain a high-interest category, but formulators often face a familiar trade-off: achieving strong fermentation-driven benefits without pushing consumers into discomfort from rapid gas production or harsh digestive effects. In this research, Organic NatureKnit was associated with what the authors described as a slow, gentle fermentation profile—paired with a sustained, long-lasting prebiotic effect.

Notably, the study reported that a 2.5-gram dose of Organic NatureKnit delivered stronger outcomes at the 48-hour mark than commonly used purified organic fibre ingredients. Reported advantages included improvements across several indicators tied to gut ecology and metabolite production, such as the total abundance of beneficial gut bacteria, bacterial species richness, and total short-chain fatty acids (SCFAs).

SCFAs—often discussed in the context of gut barrier function and metabolic signalling—are a key marker many formulators watch when comparing fermentable fibres. In this evaluation, Organic NatureKnit’s effect on total SCFAs was highlighted as part of a broader pattern of microbiome modulation.

A “whole-food fibre” approach versus purified fibres

The study positions Organic NatureKnit as an alternative to purified fibres by emphasizing complexity rather than isolation. According to FutureCeuticals, the ingredient is built from a blend of diverse fruit and vegetable fibres and includes naturally occurring, fibre-bound polyphenols—components that may help shape microbial activity in ways that differ from single-source purified fibres.

“Our NatureKnit portfolio represents an exciting fusion of our passion for creating natural, sustainable ingredients with state-of-the-art scientific research methods,” said Brendan Kesler, Innovation Director at FutureCeuticals and Postgraduate Researcher at The Rowett Institute. “This new research demonstrates that our patented blend of diverse fruit and vegetable fibres, along with naturally occurring fibre-bound polyphenols, delivers a greater and more sustained prebiotic effect compared to purified fibres within the human gut microbiome.”

What the findings could mean for formulation

For product developers, the findings point to three practical signals:

  • Lower dose potential: The reported impact at 2.5 grams may support more flexible dosing strategies, depending on product format and positioning.
  • Gentler fermentation profile: A slower fermentation curve can be relevant for consumer tolerance and repeat use—especially in everyday gut-health routines.
  • Broader microbiome modulation: The study suggests effects that extend beyond what is commonly seen with purified fibres, which may appeal to brands seeking more comprehensive microbiome positioning.

Kesler underscored that consumer expectations are also shifting: “It’s an exciting development for the nutrition industry, because Organic NatureKnit goes beyond popular purified fibres to deliver several key attributes consumers are seeking in gut health products,” he said. “It’s fully organic and sustainable, gentle, and offers a comprehensive microbiome benefit much broader than purified fibres.”

Important context for readers

While M-SHIME is a validated and widely used platform for studying microbiome interactions, it remains a controlled simulation rather than a clinical study in free-living humans. Still, model-based research like this can provide high-resolution insights into fermentation dynamics, microbial shifts, and metabolite production—often helping guide ingredient selection and informing the next steps in human research.

Bottom line

With consumers increasingly looking for organic, clean-label gut solutions that feel as good as they perform, this Frontiers in Nutrition study adds weight to the case for more complex, whole-food-derived fibre systems. Organic NatureKnit’s reported combination of gentle fermentation and sustained 48-hour outcomes—across beneficial bacteria and SCFA production—positions it as a noteworthy ingredient option for formulators exploring the next wave of prebiotic innovation.

Canada Issues Recall for Left Coast Organics Organic Chia Seeds After Salmonella Risk Flagged

0

A food recall alert has been issued in Canada for Left Coast Organics brand Organic Chia Seeds due to possible Salmonella contamination. The alert applies to product distributed in Alberta, British Columbia, Manitoba, Ontario, and Saskatchewan, and it advises consumers and retailers to stop using the affected chia seeds immediately.

Affected product details (how to confirm)

Check your package carefully. This recall applies to:

  • Brand: Left Coast Organics
  • Product: Organic Chia Seeds
  • Size: 900 g
  • UPC: 6 25691 21034 9
  • Best Before: 26 NO 13 and 26 NO 14

If your product matches the UPC and either Best Before code, treat it as recalled. Importantly, food contaminated with Salmonella may not look or smell spoiled, so appearance is not a reliable indicator of safety.

What Salmonella can look like

Salmonellosis doesn’t affect everyone the same way, but common short-term symptoms can include fever, headache, nausea, vomiting, abdominal cramps, and diarrhea. People at higher risk of severe illness include young children, pregnant women, older adults, and people with weakened immune systems. Even healthy adults can experience unpleasant symptoms and dehydration, and in some cases, longer-term complications may occur.

If you believe you became ill after consuming the recalled chia seeds, contact your healthcare provider for guidance.

What to do if you have the recalled chia seeds

Consumers are advised to:

  1. Check your pantry for the affected product (match UPC and Best Before code).
  2. Do not consume the chia seeds or use them in smoothies, baking, overnight oats, or other recipes.
  3. Do not serve the product to others.
  4. Return it to the store where purchased, or throw it out if returning isn’t possible.
  5. If the product was opened, wash hands and sanitize containers, scoops, counters, and any surfaces that may have contacted the seeds to reduce cross-contamination.

Guidance for natural health retailers and food businesses

For health food stores, cafés, and retailers that sell organic pantry staples, speed and documentation matter. Immediately:

  • Remove and quarantine all matching stock from shelves and back-of-house storage
  • Stop sale, sampling, and use in any prepared foods
  • Verify identifiers on every unit (UPC plus Best Before code)
  • Post a clear in-store notice and update online listings if applicable
  • Record counts and actions (units pulled, returned, discarded) for supplier and compliance follow-up

If your POS system tracks UPC-level purchases, consider pulling a report to support proactive customer communication.

Precision Probiotics Enter the Sleep Category

0

What Verb Biotics’ LP815 trial signals for brands, retailers, and formulation in 2026

Sleep is no longer a soft wellness promise. It is a daily-function category, a performance category, and increasingly, a credibility category. Consumers are telling the market exactly what they want: natural support that feels modern, measurable, and backed by real data. In a U.S. consumer survey of 2,000 adults commissioned by Verb Biotics, nearly three quarters reported symptoms related to mental health, including stress and poor sleep, and 40 per cent said those symptoms affect daily functioning. That is a massive demand signal, and it is not slowing down.

Into that environment comes a clinical story that is already shifting how formulators and brand teams talk about probiotics. Verb Biotics has published a human trial in Scientific Reports (with 138 participants) evaluating a proprietary strain positioned as a “GABA-supporting” precision probiotic. The study is being watched closely because it pairs two things the sleep category has historically struggled to deliver at the same time: meaningful symptom change and objective confirmation through wearable tracking.

This is not a digestive-support probiotic story. It is a gut–brain axis business story.

The study that’s driving the conversation

The trial was double-blind, randomized, and placebo-controlled, the kind of design that matters when brands need more than marketing language to earn shelf space and repeat purchase. Participants took either the probiotic or placebo daily for six weeks. Outcomes were assessed using established sleep measures, alongside wearable-derived sleep data and biomarker tracking that looked at urinary GABA levels over time.

The headline result is commercially easy to understand: 77.3 per cent of participants in the LP815 group showed a clinically meaningful improvement in sleep by week six, defined as a four-point or greater improvement on a standard sleep scale. Even more attention-grabbing for segmentation teams, the company reports that every woman in the LP815 group reported improved sleep by week six.

But the reason this story has staying power is not only what people reported. It is what the wearables confirmed. Oura Ring data showed measurable improvements in total sleep time, deep sleep duration, and reduced sleep latency, with statistical significance reported in the study materials. For the sleep aisle, where placebo effects are real and “I slept great” can be highly subjective, wearable confirmation changes the tone of the conversation. It makes the claim feel less like a vibe and more like a metric.

Why “GABA probiotic” is resonating right now

GABA, gamma-aminobutyric acid, is widely recognized in the supplement world as a neurotransmitter associated with calm and relaxation. The catch has always been turning that concept into a product experience consumers can actually feel, consistently, without unwanted trade-offs. LP815’s positioning aims to do that through a strain-specific mechanism rather than a broad category promise.

Verb Biotics describes LP815 as a proprietary strain of Lactiplantibacillus plantarum selected from a vast pool for its ability to produce high levels of GABA within the gastrointestinal tract. The brand narrative is direct: when taken orally, the strain acts as a GABA “factory” in the gut, delivering GABA through ingestion while also supporting additional production through interaction with existing microbiota.

What makes that narrative more usable for brands is the biomarker timeline. Urinary GABA reportedly increased within the first week and remained stable through week six, and stable elevation by day seven correlated with better sleep quality and improved mood indicators. For marketing and education teams, this opens the door to a more nuanced consumer expectation story: not a one-night miracle, but a short runway to measurable calm support, followed by compounding sleep benefits across a six-week window.

Stress reduction is the real multiplier

The smartest sleep products in 2026 will not sell “sleep” as an isolated problem. Consumers experience a loop: stress delays sleep, poor sleep amplifies stress, and the next day becomes the trigger for the same cycle. The LP815 trial reports improvements not only in sleep measures but also in stress-related outcomes, reinforcing the business value of dual-action positioning.

This is where the precision probiotic category becomes a meaningful strategic lane rather than a novelty. If a probiotic can credibly sit at the intersection of calm, stress resilience, and sleep architecture, it moves from a “sleep aid alternative” to a daily foundational habit. And habits are where lifetime value is built.

A surprising secondary signal: night sweats

One of the more interesting data points in the materials is that 40 per cent of participants experienced a decrease in the severity of night sweats by week six. For brands, the opportunity here is not to overreach, but to recognize how often consumers describe sleep disruption in the language of lived symptoms. When a product story acknowledges those realities carefully, it can improve relevance, especially in women-focused education and life-stage merchandising.

Tolerability: the detail that decides reorder

Sleep is one of the most abandoned categories because consumers quit quickly when products feel heavy, groggy, or disruptive. The LP815 story includes a strong tolerability angle, with no gastrointestinal symptoms or adverse effects reported in the materials provided. Whether you are selling direct-to-consumer or through health food retail, tolerability is what allows a sleep product to become “nightly,” not “occasionally.” That shift alone can change the unit economics of a sleep line.

What this means for product teams and retailers

The bigger takeaway is that probiotics are being re-framed. Probiotics are no longer only about gut comfort; they are becoming a platform for targeted outcomes, where the strain is the strategy. The market language is moving from “probiotic for general wellness” to “precision biotic for a defined function,” with clinical endpoints and objective tracking supporting the story.

For brands, this is a cue to build sleep and stress products the way the category actually sells today. A single hero ingredient with a clear evidence narrative can reduce consumer confusion, simplify staff training, and support premium pricing without relying on discounting. For retailers, objective metrics such as deep sleep duration and sleep latency are easy to translate into the language shoppers already use, especially as wearables have trained consumers to think in “sleep scores” rather than vague wellness feelings.

For formulators and ingredient buyers, the competitive question becomes simple: can you defend your sleep claims with outcomes that feel measurable, repeatable, and teachable? If you can, you will win attention. If you cannot, you will be forced to compete on price, flavour, or trend cycles.